ResearcherNankai UniversityActive in the last 2 years
Shiyu Liu
Matched on ORCID iD 0000-0001-8177-3985; OpenAlex author ID A5100355120. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 17
2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: 2 papers · 2024: none · 2025: 1 paper
Papers 5
- Oncolytic virus-induced IL-1β+ monocyte-IL-6+ CAF axis suppresses dendritic cell-mediated antitumor immunity in pancreatic cancer. Co-author DOI 10.1136/jitc-2025-013175↗
- Claudin18.2 bispecific T cell engager armed oncolytic virus enhances antitumor effects against pancreatic cancer. Co-author DOI 10.1016/j.omto.2023.08.011↗
- OX40L-Armed Oncolytic Virus Boosts T-cell Response and Remodels Tumor Microenvironment for Pancreatic Cancer Treatment. Co-author DOI 10.7150/thno.83495↗
- CD40L-armed oncolytic herpes simplex virus suppresses pancreatic ductal adenocarcinoma by facilitating the tumor microenvironment favorable to cytotoxic T cell… Co-author DOI 10.1136/jitc-2021-003809↗
- Cep70 overexpression stimulates pancreatic cancer by inducing centrosome abnormality and microtubule disorganization. Co-author DOI 10.1038/srep21263↗
Closest collaborators
The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Hongkai Zhang · 4 shared papers, 2022–2025 · strength 0.61
- Paper Oncolytic virus-induced IL-1β+ monocyte-IL-6+ CAF axis suppresses dendritic cell-mediated antitumor immunity in pancrea… DOI 10.1136/jitc-2025-013175↗
- Paper Claudin18.2 bispecific T cell engager armed oncolytic virus enhances antitumor effects against pancreatic cancer. DOI 10.1016/j.omto.2023.08.011↗
- Paper CD40L-armed oncolytic herpes simplex virus suppresses pancreatic ductal adenocarcinoma by facilitating the tumor microe… DOI 10.1136/jitc-2021-003809↗
- Youjia Cao · 3 shared papers, 2022–2025 · strength 0.45
- Paper Oncolytic virus-induced IL-1β+ monocyte-IL-6+ CAF axis suppresses dendritic cell-mediated antitumor immunity in pancrea… DOI 10.1136/jitc-2025-013175↗
- Paper CD40L-armed oncolytic herpes simplex virus suppresses pancreatic ductal adenocarcinoma by facilitating the tumor microe… DOI 10.1136/jitc-2021-003809↗
- Paper OX40L-Armed Oncolytic Virus Boosts T-cell Response and Remodels Tumor Microenvironment for Pancreatic Cancer Treatment. DOI 10.7150/thno.83495↗
- Mingjuan Du · 2 shared papers, 2023 · strength 0.29
- Paper Claudin18.2 bispecific T cell engager armed oncolytic virus enhances antitumor effects against pancreatic cancer. DOI 10.1016/j.omto.2023.08.011↗
- Paper OX40L-Armed Oncolytic Virus Boosts T-cell Response and Remodels Tumor Microenvironment for Pancreatic Cancer Treatment. DOI 10.7150/thno.83495↗
- Ruikun Wang · 2 shared papers, 2022–2023 · strength 0.27
- Paper CD40L-armed oncolytic herpes simplex virus suppresses pancreatic ductal adenocarcinoma by facilitating the tumor microe… DOI 10.1136/jitc-2021-003809↗
- Paper OX40L-Armed Oncolytic Virus Boosts T-cell Response and Remodels Tumor Microenvironment for Pancreatic Cancer Treatment. DOI 10.7150/thno.83495↗
- Fan Li · 1 shared paper, 2025 · strength 0.19
- Jie Wang · 1 shared paper, 2025 · strength 0.19
- Yuanke Li · 1 shared paper, 2025 · strength 0.19
- Feilong Zhou · 1 shared paper, 2025 · strength 0.19
- Zhaoyuan Zhang · 1 shared paper, 2025 · strength 0.19
- Cuizhu Zhang · 1 shared paper, 2022 · strength 0.13
- Yuan Wang · 1 shared paper, 2023 · strength 0.13
- Wenrui Gao · 1 shared paper, 2023 · strength 0.13
- Wei Wang · 1 shared paper, 2023 · strength 0.13
- Jun Zhou · 1 shared paper, 2016 · strength 0.06
- Dengwen Li · 1 shared paper, 2016 · strength 0.06
- Songbo Xie · 1 shared paper, 2016 · strength 0.06
- Min Liu · 1 shared paper, 2016 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.